Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases

The contract focuses on the development of medical countermeasures to address threats related to biodefense and emerging infectious diseases. It is overseen by the National Institutes of Health and falls under the NAICS code 541714, which relates to research and development in biotechnology. The initiative aims to support innovative research and development efforts that will enhance preparedness and response capabilities against biological threats and novel infectious agents. Key contacts for this contract include Paul Eder, serving as the program point of contact, and Alexandra Buck, the contracting officer. While specific location details for the place of performance are not provided, the contract represents an opportunity for organizations involved in advanced biomedical research to contribute to public health security. Further details and updates are accessible through the NIH industry opportunity forecast portal.